GL1X · GenesisL1 explorer

MolNFT v1 · #181394 · protein

Crystal structure of mpro in complex with inhibitor cdd-1713

7LTN · 3C-like proteinase: “Crystal structure of mpro in complex with inhibitor cdd-1713”. X-ray diffraction, 1 ligand (YCV), 2 pockets (best druggability 0.49). MolNFT v1 #181394 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
7LTN
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
YCV
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 29% strandP0DTD1

Ligands and binding sites

  • YCV · 2-[4-(1~{H}-indazol-4-yl)-2-methanoyl-6-methoxy-phenoxy]-~{N},~{N}-dimethyl-ethanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.490.7627YCV
2770.320.7416empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7LTN · Crystal structure of Mpro in complex with inhibitor CDD-1713 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.